Literature DB >> 10196361

Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1.

Y Xue1, X Gao, C E Lindsell, C R Norton, B Chang, C Hicks, M Gendron-Maguire, E B Rand, G Weinmaster, T Gridley.   

Abstract

The Notch signaling pathway is an evolutionarily conserved intercellular signaling mechanism essential for embryonic development in mammals. Mutations in the human JAGGED1 ( JAG1 ) gene, which encodes a ligand for the Notch family of transmembrane receptors, cause the autosomal dominant disorder Alagille syndrome. We have examined the in vivo role of the mouse Jag1 gene by creating a null allele through gene targeting. Mice homozygous for the Jag1 mutation die from hemorrhage early during embryogenesis, exhibiting defects in remodeling of the embryonic and yolk sac vasculature. We mapped the Jag1 gene to mouse chromosome 2, in the vicinity of the Coloboma ( Cm ) deletion. Molecular and complementation analyses revealed that the Jag1 gene is functionally deleted in the Cm mutant allele. Mice heterozygous for the Jag1 null allele exhibit an eye dysmorphology similar to that of Cm /+ heterozygotes, but do not exhibit other phenotypes characteristic of Cm /+ mice or of humans with Alagille syndrome. These results establish the phenotype of Cm /+ mice as a contiguous gene deletion syndrome and demonstrate that Jag1 is essential for remodeling of the embryonic vasculature.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196361     DOI: 10.1093/hmg/8.5.723

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  227 in total

1.  CADASIL: Notch signaling defect or protein accumulation problem?

Authors:  N B Spinner
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

2.  Notch signaling is essential for vascular morphogenesis in mice.

Authors:  L T Krebs; Y Xue; C R Norton; J R Shutter; M Maguire; J P Sundberg; D Gallahan; V Closson; J Kitajewski; R Callahan; G H Smith; K L Stark; T Gridley
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

3.  Members of the Jagged/Notch gene families are expressed in injured arteries and regulate cell phenotype via alterations in cell matrix and cell-cell interaction.

Authors:  V Lindner; C Booth; I Prudovsky; D Small; T Maciag; L Liaw
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  Notch signaling during vascular development.

Authors:  T Gridley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

5.  Altered Notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects.

Authors:  Sarbjit S Nijjar; Lorraine Wallace; Heather A Crosby; Stefan G Hubscher; Alastair J Strain
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 6.  Molecular control of arterial-venous blood vessel identity.

Authors:  Ralf H Adams
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

7.  Notch activation of Jagged1 contributes to the assembly of the arterial wall.

Authors:  Lauren J Manderfield; Frances A High; Kurt A Engleka; Feiyan Liu; Li Li; Stacey Rentschler; Jonathan A Epstein
Journal:  Circulation       Date:  2011-12-06       Impact factor: 29.690

Review 8.  Alagille syndrome: pathogenesis, diagnosis and management.

Authors:  Peter D Turnpenny; Sian Ellard
Journal:  Eur J Hum Genet       Date:  2011-09-21       Impact factor: 4.246

Review 9.  The notch pathway: modulation of cell fate decisions in hematopoiesis.

Authors:  K Ohishi; B Varnum-Finney; I D Bernstein
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

10.  Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome.

Authors:  Jennifer J Hofmann; Anais Briot; Josephine Enciso; Ann C Zovein; Shuxun Ren; Zhen W Zhang; Freddy Radtke; Michael Simons; Yibin Wang; M Luisa Iruela-Arispe
Journal:  Development       Date:  2012-10-24       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.